The weight loss pills vs injections choice comes down to three questions: which format loses more weight, which costs less per month, and which one you will actually stick with. On trial results, injections lead — injectable semaglutide averaged about 14.9% body-weight loss over 68 weeks in the STEP 1 trial, and injectable tirzepatide reached up to 20.9% over 72 weeks in SURMOUNT-1. Pills push back on comfort and entry price: FDA-approved oral GLP-1s now start at $149 per month, with no needle involved.
This page only ranks providers that sell both formats, so you can pick a pill, a pen, or a vial — or switch later — without changing companies. Across the wider market, injections run roughly $99 to $399 per month; at these five providers, needle-free options start between $149 and $249. All prices were verified on official provider sites and terms in July 2026, and every score is an editorial rating built from documented research, not first-hand testing.
1. Hers — Three Real Pills Next to Real Pens
Hers, the women’s telehealth brand of NYSE-listed Hims & Hers Health, carries the deepest needle-free menu in this comparison: the Wegovy pill, Ozempic pill, and Foundayo pill, each from $149/month. If pills disappoint you, injectable Wegovy pens (from $199/month) and Zepbound formats (from $299/month) sit on the same pricing page. That two-way flexibility, more than any single price, is why our Hers review puts it first on this specific page.
Pricing Structure
Every medication price rides on top of a required Weight Loss Membership: $39 the first month, then $149/month, billed separately. Hers states plainly that the membership does not include or guarantee a prescription.
Pills run from $149/month, Wegovy and Ozempic pens from $199/month, and Zepbound vial or KwikPen from $299/month. These are ‘from’ prices that rise at higher doses, and Hers does not publish a full dose-by-dose table. Per third-party pricing reports from July 2026, the cheapest realistic first month totals about $193 including $5 shipping, with ongoing costs near $303/month.
Pros & Cons
Pros: BBB A+ rating and roughly 3.8/5 across ~7,000 customer reviews — the best reputation numbers in this ranking. Asynchronous visits in all 50 states, with provider review typically within 24 hours and no lab work required. Every pill and pen on the current menu is FDA-approved and brand-name.
Cons: Insurance is not accepted, so the membership and the medication are both cash bills. Refunds are narrow — only unshipped initial orders canceled within 48 hours qualify, and canceling your medication does not cancel the membership. History counts against it too: the FDA sent Hers a September 2025 warning letter over compounded semaglutide marketing, and Novo Nordisk sued the company in February 2026; compounded product is now limited to medical necessity.
2. Ro — Highest Score Overall, First to the Wegovy Pill
Ro holds the top score in this comparison at 8.8/10 and was among the first telehealth platforms to offer the Wegovy pill in January 2026, per its own press releases. Everything on its menu — pills and pens alike — is FDA-approved and brand-name, sourced through Novo Nordisk’s NovoCare and Eli Lilly’s LillyDirect channels. It ranks second here for one reason: its $149 pill price is an intro rate that rises after month one, while Hers holds $149 as its ongoing starting price. Full scoring is in our Ro review.
Pricing Structure
Membership costs $39 the first month, then $149/month, dropping to about $74/month with a full annual prepay — and Ro charges it only if you are found eligible for treatment. The Wegovy pill and Foundayo pill cost $149 the first month, then $199–$299/month, cash-pay only with no insurance route.
On the injection side, the Wegovy pen runs $199 the first month, then $199–$399 by dose; the Zepbound KwikPen starts at $299, then $399–$449. With insurance, injectable medication can drop to a copay: Ro runs a free coverage check and its concierge files prior-authorization paperwork, which takes 2–3 weeks when needed.
Pros & Cons
Pros: Zero compounded products anywhere on the menu. Serves all 50 states plus D.C., is BBB-accredited since 2018 (B rating), and bills membership only after an eligibility decision. Its insurance support is genuinely useful for pens — something no compounded competitor on this page offers.
Cons: Two separate bills make Ro expensive in cash — realistically $350+ per month at maintenance pen doses. Reputation is mixed: Trustpilot around 3.7/5 across 2,300+ reviews and 610 BBB complaints, many about membership billing clarity. Ro also requires that you have seen a healthcare provider within the past 3 years.
3. MEDVi — Where Injections Beat Pills on Price
MEDVi flips the assumption this page exists to test. Its compounded semaglutide injection costs $179 the first month and a flat $299/month after, while its daily dissolvable tablets start higher, at $249 the first month — and tablet refill prices are not published at all. Both formats are compounded, which means not FDA-approved, a fact MEDVi’s own site discloses. Our MEDVi review unpacks its sharply split reputation.
Pricing Structure
The injection plan is all-inclusive — consultation, medication, expedited shipping, and support — at $179 the first month and a flat $299/month at every dose afterward. Tablets start at $249 the first month, with third-party reviews citing refills up to $369. Compounded tirzepatide starts around $349, with third-party reports putting refills at $399–$499 depending on dose.
Brand-name Wegovy and Zepbound run through a separate track with a $99 membership plus medication cost; the company’s own January 2026 press release lists Ozempic at $1,999/month. HSA and FSA payments are accepted. One third-party review site reports billing on a 28-day cycle — about 13 charges per year, not 12.
Pros & Cons
Pros: Injection refills stay flat during dose escalation. MEDVi names its compounding pharmacies publicly — Triad Rx, RedRock Pharmacy, and Beaker Pharmacy & Compounding — and prescribing runs through OpenLoop Health clinicians, usually within 24 hours. Trustpilot shows a strong ~4.4/5 across roughly 14,000 reviews.
Cons: The BBB record is the opposite story: an F rating with 662 complaints, 100 of them unanswered, plus recurring reports of auto-renewal charges (often $399) and double billing. Refunds are generally unavailable once a cycle’s medication is dispensed. Coverage is 49 states, not 50, and the unpublished tablet refill price is a real problem for pill-first shoppers.
4. OMZO — One Bundled Price, Either Format, Thin Paper Trail
OMZO sells compounded semaglutide injections at $199 for the first month — its own terms note the program was originally priced at $179 — then $299/month locked regardless of dose. Oral dissolvable GLP-1 tablets are listed from $249. Consultation, prescription, medication, and shipping come bundled with no contract, but our OMZO review found a company with almost no third-party track record to check that promise against.
Pricing Structure
Per OMZO’s terms: semaglutide $199 the first month, then $299/month; compounded tirzepatide $349 the first month, then $399/month. Brand-name Ozempic appears at $1,299/month in the terms but ‘starting at $1,999/mo’ in the site navigation — an unexplained gap — and Zepbound vials are listed at $1,399/month.
Shipping is free, everything is cash-pay, and you can cancel future charges anytime. Refund requests must be made within 28 days of payment, by email only.
Pros & Cons
Pros: Refills are genuinely locked at one price with no dose tiers. You get a full refund if a clinician finds you medically ineligible, and a stated full refund if medication has not shipped within 14 business days. Both formats are available in all 50 states, per its terms.
Cons: OMZO does not name its compounding pharmacies or disclose 503A/503B status. Its binding terms allow refunds only for ineligibility or billing errors, which contradicts its money-back marketing. The verification problem is bigger still: about 7 Trustpilot reviews, no BBB profile, and no legal entity name or business address anywhere in its terms.
5. Sprout Health — The Needle-Free Format Nobody Else Has, With Warnings
Sprout Health carries the one format no other provider here offers: sublingual semaglutide that dissolves under the tongue — no needle, no swallowed pill. Its compounded semaglutide starts at $149/month with a written guarantee that the price never rises with your dose. Then comes the record: an FDA warning letter, a BBB F rating, and a 2.2/5 Trustpilot score, all documented in our Sprout Health review.
Pricing Structure
Verified on the official site in July 2026: compounded semaglutide from $149/month, with a 3-month supply promoted at $465 (about $155/month, regular $615). Compounded tirzepatide is promoted from $199/month (regular $349). Brand-name Wegovy ($1,799/month) and Zepbound ($1,999/month) are listed for buyers who insist on FDA-approved product.
There is no membership or consultation fee, and delivery typically takes 5–7 business days after a prescription. Note that displayed prices are promotional and have shifted over time, per third-party reviews.
Pros & Cons
Pros: The lowest compounded entry price in this ranking, a price-lock that is stated in writing on the official site, and a refund if the clinician rules you ineligible. The sublingual format is a genuine option for people who can tolerate neither needles nor daily pills.
Cons: The FDA cited Sprout Health in a September 9, 2025 warning letter for falsely claiming its compounded GLP-1s were FDA-approved; the site now discloses they are not. The BBB shows an F rating with 32 of 63 complaints unanswered, and Trustpilot sits near 2.2/5 with 84% one-star reviews per search-visible data. The company has only existed since January 2025, does not name its pharmacies, and cannot ship compounded medication to Arkansas, Kansas, or New Mexico.
Weight Loss Pills vs Injections: Which Actually Works Better?
The strongest published numbers belong to injections. In the STEP 1 trial, weekly injectable semaglutide (2.4 mg) plus lifestyle changes produced about 14.9% average body-weight loss over 68 weeks, versus 2.4% for placebo. In SURMOUNT-1, weekly injectable tirzepatide reached up to 20.9% over 72 weeks at the highest dose.
FDA-approved pills are simply newer. The Wegovy pill only reached telehealth menus in January 2026, so choose it for convenience and needle avoidance — not because it has a deeper evidence base than the pens. And the compounded dissolvable tablets and sublingual formats sold by MEDVi, OMZO, and Sprout Health have no large published trials at all; with those, you are trusting a compounding pharmacy, not trial data.
Side effects do not split cleanly by format. Every product on this page belongs to the same GLP-1 class, so expect the same core issues — nausea, vomiting, diarrhea, constipation — concentrated during dose increases. Our GLP-1 side effects guide covers what is normal and what needs a doctor.
How We Ranked These Weight Loss Pills vs Injections Providers
Every score comes from the 5-factor rubric on our How We Rank page: pricing transparency (30%), total cost (25%), safety and sourcing disclosure (20%), service flexibility (15%), and reputation (10%). To make this list at all, a provider had to sell both an injectable and a needle-free GLP-1 format on its own product pages as of July 2026.
One ordering note deserves plain language: Ro outscores Hers 8.8 to 8.5 on the overall rubric, but this page orders providers by dual-format value. Hers takes first because its $149/month pill price is an ongoing starting rate, while Ro’s $149 covers one month before climbing to $199–$299. We do not test medications personally, and the commission relationships disclosed above do not move scores.
Which Hidden Fees Change the Pills-or-Injections Math?
Memberships flip the winner. Fees, not sticker prices, decide most weight loss pills vs injections budgets. Hers and Ro both add $149/month after the first month — $1,788 per year before any medication ships. That turns a $149 pill into roughly a $300/month commitment, which is more than MEDVi’s or OMZO’s $299 all-inclusive injection refills.
Promo cliffs hit both formats. MEDVi’s injection jumps from $179 to $299 after month one — a 67% increase. OMZO steps from $199 to $299, and Ro’s pill goes from $149 to $199–$299. Judge every offer by its month-two price, not its headline.
Unpublished refill prices are a red flag. MEDVi’s tablets start at $249 with no published refill price (third parties report up to $369). Never start a format whose second-month cost you cannot see in writing. One third-party review also reports MEDVi bills on a 28-day cycle — about 13 charges a year. The full line-item math for every fee type lives in our GLP-1 cost breakdown.
Who Qualifies, and How Does Prescribing Differ by Format?
The medical bar is identical for pills and injections: generally a BMI of 30 or higher, or 27+ with a weight-related condition like high blood pressure or type 2 diabetes. Expect rejection if you have a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, a history of pancreatitis, are pregnant or planning pregnancy, or have an active eating disorder.
The process is the same too: a 10–20 minute health questionnaire, asynchronous review by a state-licensed clinician (some states require video), and shipping in roughly 2–7 days if approved. A legitimate provider rejects unqualified applicants — several companies on this page state that payment never guarantees a prescription, and that is a good sign.
The difference shows up at your door. Injections arrive as vials or pens you inject weekly, and technique matters — our step-by-step guide on how to inject semaglutide covers sites, angles, and storage. Pills and dissolvable tablets are a daily habit instead, and sublingual doses have their own hold-under-the-tongue instructions. Pick the routine you will still be following in week 30, because in every trial cited on this page, the results came from people who stayed on the medication.